| Danhauser-Riedl, Susanne (4SC 201401– CMO before GSK GmbH + MedacSchering Onkologie GmbH) |
Chief Medical Officer (CMO) |
4SC (Group) |
Germany |
| Daniel, Hannelore (TU Munich 200608 Prof) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Daniel, Rolf (Univ Göttingen 201311 Professor) |
Professor |
Norddeutsches Zentrum für Mikrobielle Genomforschung (NZMG) |
Germany |
| Daniell, Wayne (NanoScape AG 201102 CEO) |
Chief Executive Officer (CEO) |
NanoScape AG |
Germany |
| Daniels, Graeme (Andrew Alliance 201809– VP Business Development before ADInstruments + Cytocentrics + Tecan UK) |
Business Development Manager / Strategy Manager |
Waters (Group) |
Switzerland |
| Danielsson, Gusten (Cellink 201908 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Cellink (Group) |
Sweden |
| Danne, Doug (Lonza 201010 Head Rapid Testing Solutions business unit) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Dannenberg, Jens (Qiagen 200706 Global Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| Danner, Stefan (Maiwald Patentanwalts-GmbH 200809 patent attorney) |
Patent Attorney |
Maiwald Patentanwalts GmbH (Munich) |
Germany |
| Dannfeld, Robert (Pharmatio GmbH 201708 Managing Director) |
Managing Director |
Pharmatio GmbH |
Germany |
| Dansky, Peter M. (Agena Bioscience 201407– CEO before Life Technologies + Applied Biosystems + Arcturus + Affymetrix) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
| Danzl, Michael (Actelion 201606 General Manager at Actelion Germany) |
General Manager (management) |
Johnson & Johnson (JnJ) (Group) |
Germany |
| Darbouret, Bruno (Thermo Fisher 201109 Director RnD BRAHMS Biomarkers) |
Research & Development Manager |
Thermo Fisher (Group) |
Germany |
| Darcissac, Camille (Adocia 202005 Business Development + Strategic Marketing) |
Business Development Manager / Strategy Manager |
Adocia S.A. |
France |
| Dargel, Christian (Breakpoint Therapeutics 201906– Managing Director) |
Managing Director |
Breakpoint Therapeutics GmbH |
Germany |
| Darr, William (ADF/IDF 201901 Founder) |
Company Founder |
Symrise (Group) |
United States (USA) |
| Dartsch, Stefan (Ionovation 201206 Managing Director) |
Managing Director |
Ionovation GmbH |
Germany |
| Dasberg, David (Facio Therapies 201504 Managing Director) |
Managing Director |
Facio Therapies B.V. |
Netherlands |
| Datla, Vijay Kumar (Biological E 201109 Managing Director) |
Managing Director |
Biological E. Ltd. |
India |
| Datta, Merrilyn (Definiens 201304– Chief Marketing Officer based in Carlsbad, CA before Life Technologies) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
United States (USA) |
| Daub, Achim (Symrise 201404 Global President Scent + Care) |
President/Director/Head Business Group/Unit/Division |
Symrise (Group) |
Germany |
| Daub, Henrik (MPI for Biochemistry 200603) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
| Daujotyte, Dalia (Lexogen 201806 Head of Business Development) |
Business Development Manager / Strategy Manager |
Lexogen GmbH |
Austria |
| Daum, Dieter (Sony 201203 CEO of Sony DADC) |
Chief Executive Officer (CEO) |
Sony (Group) |
Austria |
| Daumke, Philipp C. (Averbis GmbH 2007– Managing Director + Co-Founder) |
Managing Director |
|
Germany |
| Dausend, Melanie (Univ Wuppertal 201005 Analytical Service Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Wuppertal |
Germany |
| David, Rainer (Eppendorf 201709 Managing Director at Eppendorf Polmyere GmbH) |
Managing Director |
Eppendorf (Group) |
Germany |
| Davidson, Eran (HassoPlattnerVentures 200506 + DBI AG 201508 Supervisory Board Member) |
Investment Manager |
HassoPlattnerVentures Management GmbH |
Germany |
| Davidson, Jostein (Nycomed 201108 SVP + President of Nycomed Russia-CIS) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Switzerland |
| Davies, Hugh (Kinesis 201201 Managing Director of Abimed GmbH) |
Managing Director |
Cole-Parmer (Group) |
Germany |
| Davies, Mike (F-Star 201606 VP Protein Science) |
n. a. |
F-Star (Group) |
United Kingdom (GB) |
| Davies, Richard (BoneSupport 201601– CEO before Hospira CCO) |
Chief Commercial Officer (CCO) |
BoneSupport (Group) |
Sweden |
| Davies, Steve (Markes International 201212 Product Manager at Almsco International) |
Product Manager (personnel) |
Schauenburg (Group) |
United Kingdom (GB) |
| Davis, Darren (ApoCell 201311 CEO) |
Chief Executive Officer (CEO) |
ApoCell (Group) |
United States (USA) |
| Davis, Paul (Roivant 201708 Manager Communications Strategy) |
Public Relations Manager / Investor Relations Manager |
Roivant (Group) |
United States (USA) |
| Dawson, John (Alliance Pharma 201306 CEO + Founder) |
Chief Executive Officer (CEO) |
Alliance Pharma (Group) |
United Kingdom (GB) |
| Day, Adrienne (Burnham 200611 VP Business Development) |
Business Development Manager / Strategy Manager |
Burnham Institute |
United States (USA) |
| de Angelis, Hrabe (GSF Munich 200705– Director) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| De Backer, Marianne (Bayer 202008 Excecutive Committee Memmber + Head of Strategy + BusDev + Licensing at Pharma div) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
| de Baey-Diepolder, Annegret (Rigontec 201410 Managing Director before GIMV + TVM Capital + Micromet) |
Managing Director |
Merck (US) (MSD) (Group) |
Germany |
| De Beuckelaer, Ann (BioMed X 201609 Managing Director) |
Managing Director |
BioMed X GmbH |
Germany |
| de Bie, Johannes Hendrik (Hans) (WeissBioTech 201210– Managing Director) |
Managing Director |
BRAIN (Group) |
Germany |
| de Boer, Mark (Index Ventures 200708 General Partner) |
Venture Partner |
Index Ventures |
Switzerland |
| de Bruijn, Joost (Kuros 201711– CEO before Managing Director + Co-Founder of Xpand Biotechnology before IsoTis) |
Chief Executive Officer (CEO) |
Kuros (Group) |
Switzerland |
| de Buijzer, Erwin (Humedics GmbH 201205– Managing Director before Eurotransplant + Dutch Transplant Foundation + Abbott) |
Managing Director |
Humedics GmbH |
Germany |
| de Buman, Jean-Luc (SGS 201505 Corp Development, Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| de Crémoux, Isabelle (BPCE 201110– CEO of Seventure Partners) |
Chief Executive Officer (CEO) |
BPCE (Group) |
France |
| De Greef-Safft, Anne (Danaher 200901 President Leica Microsystem Biosystems Division) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
| de Haard, Hans (Argen-X 201203 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Argenx (Argen-X) (Group) |
Netherlands |
| De Haes, Patrik (ThromboGenics 200808– CEO before Roche Diagnostics) |
Chief Executive Officer (CEO) |
Oxurion (Group) |
Belgium |
| de Jager, Jost (Schleswig-Holstein 201004 Minister of Science, Economic Affairs and Transport) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
| De Jesus, Linda (Thermo Fisher 202003 VP + General Manager High Performance Chromatography Solutions) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
| de La Fortelle, Eric (Delenex 201102– CEO before Roche) |
Partner (venture partner) |
BPCE (Group) |
France |
| de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia) |
Chief Executive Officer (CEO) |
Expedeon (Group) |
Germany |
| de Lange, Lex (Zernike 201008) |
Chief Executive Officer (CEO) |
Zernike (Group) |
Netherlands |
| De Leenheer, Frank (Gimv 201509 IR + Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Gimv (Group) |
Belgium |
| de Léon, Alethia (Basel (govt) 201702 Managing Director of BaseLaunch) |
Managing Director |
Basel (govt city) |
Switzerland |
| De Libero, Gennaro (Univ Basel 201506 Professor of Immunology) |
Professor |
University of Basel |
Switzerland |
| De Paoli, Isabel (Merck (DE) 201508– Head Group Communications joined Merck 2006 before Boston Consulting + Permira) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| De Ponti, Roberto (Helsinn 201804 Head New Venture + Strategic Investment at Helsinn International Services) |
Investment Manager |
Helsinn (Group) |
Monaco |
| de Rubertis, Francesco (Medecxi Ventures 201602 General Partner before Index Ventures 200708 General Partner) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| de Ruiter, Tjerk (EuropaBio 201809 Chair) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| de Schoulepnikoff, Laurence (Amal Therapeutics 201907 CBO) |
Chief Business Officer (CBO) |
Boehringer Ingelheim (Group) |
Switzerland |
| de Vries, Sijmen (Pharming 200810– CEO before 4-Antibody CEO before Morphochem before Novartis + SKB) |
Chief Executive Officer (CEO) |
Pharming (Group) |
Netherlands |
| de Wit, Christina (Germany (govt) 201604 BMBF Division Bio-Economy) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| de Wit, Hugo (Cellca GmbH 201201– Managing Director before CBO) |
Managing Director |
Sartorius (Group) |
Germany |
| Debatin, Jörg F. (General Electric 201408– CP + CTO at GE Healthcare before Amedes + Univ Medical Center Eppendorf) |
Chief Technology/Technical Officer (CTO) |
General Electric (Group) |
United Kingdom (GB) |
| Debel, Karsten (Zytomed Systems 200912 Managing Director) |
Managing Director |
Zytomed Systems GmbH |
Germany |
| deBethizy, J. Donald (Santaris Pharma 201401– CEO before Targacept CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark |
| Debruyne, Luc (GSK 201504 President of GSK Vaccines) |
President/Director/Head Business Group/Unit/Division |
GlaxoSmithKline (GSK) (Group) |
Belgium |
| Debus, Nils (Schering 200503) |
n. a. |
Bayer (Group) |
Germany |
| Dec, Timothy C. (OpGen 201909 CFO) |
n. a. |
OpGen (Group) |
United States (USA) |
| Decker, Elke (GATC 200701 Senior Director Marketing) |
n. a. |
Eurofins (Group) |
Germany |
| Deckers, Sjaak (G-Therapeutics 201604 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
G-Therapeutics (Group) |
Netherlands |
| Deckert, Volker (University of Jena + Leibniz Institute of Photonic Technology) |
Researcher (university / research institute) |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
| Decouttere, Frederik (Genohm 2010– CEO before CTO + Co-Founder) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Switzerland |
| Deda, Henri (Lipotype 201802– Marketing Assistant) |
n. a. |
Lipotype GmbH |
Germany |
| Deeg, Maria (Creather Venture 201207 Investment Managerin) |
Investment Manager |
Creathor Ventures (Group) |
Germany |
| Dehning, Carsten (Emergence Therapeutics 202006 CFO before Albireo 201204 CFO before DeveloGen CFO) |
Chief Financial Officer (CFO) |
Emergence Therapeutics (Group) |
Germany |
| Deichmann, Annette (GeneWerk GmbH 201709 Managing Director) |
Managing Director |
GeneWerk GmbH |
Germany |
| Deichmann, Thomas (BRAIN AG 201712 Head of Public Relations) |
Public Relations Manager / Investor Relations Manager |
BRAIN (Group) |
Germany |
| Deininger, Sören-Oliver (Bruker 200905 Bruker Daltonics MALDI Imaging Specialist) |
n. a. |
Bruker (Group) |
United States (USA) |
| Deininger, Werner (Entelechon GmbH 200709 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
| Dekeyser, Rudy (Life Sciences Partners 201403 Managing Partner LSP HEF) |
Managing Partner |
Life Sciences Partners (LSP) |
Netherlands |
| Dekkers, Marijn E. (Bayer 201001–201612 CEO before Thermo Fisher CEO TO LEAVE Bayer 12/16) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Del Bono, Alessandro (Mediolanum 201612 CEO) |
Chief Executive Officer (CEO) |
Mediolanum (Group) |
Italy |
| Del Bono, Cristina (Mediolanum 201612 Licensing + Business Development Director) |
Business Development Manager / Strategy Manager |
Mediolanum (Group) |
Italy |
| del Castillo, Juan Carlos (Genetrix 201207 Operations Director) |
Chief Operating Officer (COO) |
Expedeon (Group) |
Spain (España) |
| Del Fabro, Alessandro (Evolva 201807 VP Finance) |
Chief Financial Officer (CFO) |
Evolva (Group) |
Switzerland |
| Delaite, Patricia (Nouscom 202002– CMO before Amal Therapeutics before Incyte + Ariad + Novartis + Eli Lilly) |
Chief Medical Officer (CMO) |
Nouscom (Group) |
Switzerland |
| Delansorne, Rémi (Hybrigenics 201110 CEO) |
Chief Executive Officer (CEO) |
Hybrigenics (Group) |
France |
| Delcourt, Marc (Global Bioenergies 201311 CEO) |
Chief Executive Officer (CEO) |
Global Bioenergies (Group) |
France |
| Delenda, Christophe (Cellectis 201107 CSO of Cellectis Bioresearch) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cellectis (Group) |
France |
| Delepierre, Muriel (Institut Pasteur 201703 Professor) |
Professor |
Institut Pasteur |
France |
| Della Chà, Alessandro (Cosmo Pharmaceuticals 201507 CEO) |
Chief Executive Officer (CEO) |
Cosmo Pharmaceuticals (Group) |
Luxembourg |
| Dellapa, John (Neurimmune 201903– General Counsel before Mintz Levin Cohn Ferris Glovsky Popeo + Fisher Scientific) |
General Counsel / Chief Legal Officer (CLO) |
Neurimmune AG |
Switzerland |
| Delporte, Olivier (Miracor 201801 CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Belgium |
| Delvos, Ulrich (Curacyte 200811– CEO before 4y Medigene COO until 5/08 before Aventis Behring) |
Chief Executive Officer (CEO) |
Medigene (Group) |
Germany |
| DeMan, Denise (Dee Dee) (Bench International 1974–201207– CEO + Founder) |
Chief Executive Officer (CEO) |
Bench International (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 12 13 14 ... 73 74 75 
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
